Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Patent
1995-05-23
1997-03-11
Guzo, David
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
530324, A61K 3921
Patent
active
056098766
ABSTRACT:
The present invention discloses peptide vaccines and associated methods for protection against feline leukemia virus (FeLV). The synthetic peptides of the present invention retain their secondary structural identity, stimulate antibodies reactive to the whole virus and elicit a cellular response in vaccinations. These synthetic peptides are inexpensive to produce, stable and permit easy differentiation of vaccinated versus FeLV-infected cats.
REFERENCES:
patent: 4789702 (1988-12-01), Nunberg
Nick, et al., 1990, Virus Neutralizing and Enhancing Epitodes Characterized y Synthetic Oligo-Peptides Durived from the Feline Leukemia Virus Glycoprotein Sequence, J. Gen. Virol. 71: 77-83.
Pedersen, et al., 1979, Safety and Efficacy Studies of Live-and Killed-Feline Leukemia Virus Vaccines, Am, J. Vet. Res. 40: 1120-1126.
Hoover, et al., 1991, Protection Against Feline Leukemia Virus Infection By Use of Innactivated Virus Vaccine, J. Am. Vet. Med. Assoc. 199: 1392-1401.
Nicolaisen-Strouss, 1987, Natural Feline Leukemia Virus Variant Escapes Neutralization By a Monoclonal Antibody via Amino Acid Change Outside the Antibody-Binding Epitope, J. of Virol. 61: 3410-3415.
Pedersen, et al., 1986, Possible Amino Enhancement Immunoenhancement of Persistent Viremia by Feline Leukemia Virus Envelope Glycoprotein Vaccines in a Challenge-Exposure Situations Where Whole Innactivated Virus Vaccines Where Protective, Vet. Immunol. Immunopathol. 11: 123-148.
Gilbert, et al., 1987 Feline Leukemia Virus Envelope Protein Expression Encoded by a Recombinant Vaccinia Virus: Apparent Lack of Immunogenicity in Vaccinated Animals, Virus Res. 7: 49-67.
Lewis, et al., L., 1981, Protection Against Feline Leukemia by Vaccination with a Subunit Vaccine, Infect. Immun. 34: 888-894.
Mastro et al., 1986, Feline Leukemia Vaccine: Efficacy, Contents and Probable Mechanism, Vet. Immunol. Immunopath. 11: 205-213.
Lewis, et al., 1988, Feline Leukemia Virus Vaccine: New Developments, Vet. Microbiology 17: 297-308.
Kowalski, et al., 1987, Functional Regions of the Envelope Glycoprotein of Human Immunodeficiency Type 1, Science 237: 1351-1355.
Dalgleish, et al., 1984, The CD (T4) Antigen is an Essential Component of the Receptor for the Aids Retrovirus, Nature 312: 763-766.
Bosch, et al., 1989, Identification of the Fusion Peptide of Primate Immunodeficiency Virus, Science 244:694-697.
Battini, et a l., 1992, Receptor Choice Determinants in the Envelope Glycoproteins of Amphotropic, Xenotropic, and Polytropic Murine Leukemia Viruses, J. Virol. 66: 1468-1475.
Donahue, et al., 1991, Viral Genetic Determinants of T-Cell Killing and Immunodeficiency Disease Induction by the Feline Leukemia Virus FeLV-FAIDS, J. Virol. 65: 4461-4469.
Willey, et al., 1989, Functional Interaction of Constant and Variable Domains of Human Immunodeficiency Virus Type 1 gp120, J. Virol. 63: 3595-3600.
Palker, et al., 1988, Type-Specific Neutralization of the Human Immunodeficiency Virus with Antibodies to Env-Encoded Synthetic Peptides, Proc.Natl. Acad. Sci. USA 85: 1932-1936
Dyson, et al., 1992, Immunogenic Peptides Corresponding to the Dominant Antigenic Region Alanine-597 to Cysteine-619 in the Transmembrane Protein of Simian Immunodeficiency Virus Have a Propensity to Fold in Aqueous Solution, Biochemistry 31: 1458-1463.
Nunberg, et al., 1984, Method to Map Antigenic Determinants Recognized by Monoclonal Antibodies: Localization of a Determinant Virus Neutralization on the Feline Leukemia Virus Envelope Protein GP70, Proc. Natl. Acad. Sci. USA 81: 3675-3679.
Elder et al (1987). J. Virol. 61(1), 8-15.
Weijer et al. (1993) Vaccine 11(9), 946-956.
Fontenot J. Darrell
Montelaro Ronald C.
Brusca John S.
Guzo David
University of Pittsburgh of the Commonwealth System of Higher Ed
LandOfFree
Peptide vaccines and associated methods for protection against f does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptide vaccines and associated methods for protection against f, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide vaccines and associated methods for protection against f will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-441353